/CELG-RI

CELG-RI Stock - Bristol-Myers Squibb Company Ce

Q: What is the analyst price target for CELG-RI?

Analyst price target information is not currently available for CELG-RI.

Q: What is CELG-RI's market cap?

Market capitalization information is not currently available for CELG-RI.

Healthcare|Drug Manufacturers - General|NYSE

$0.04+19.62%

+$0.01 (+19.62%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.05

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CELG-RI

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.30

52W High$0.04

52W Low$0.04

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$48.30B	$45.01B	$46.16B	$46.38B	$42.52B
Gross Profit	$27.43B	$34.31B	$36.02B	$36.45B	$30.75B
Gross Margin	56.8%	76.2%	78.0%	78.6%	72.3%
Operating Income	$9.66B	$8.20B	$9.10B	$8.54B	$2.18B
Net Income	$-8,948,000,000	$8.03B	$6.33B	$6.99B	$-9,015,000,000
Net Margin	-18.5%	17.8%	13.7%	15.1%	-21.2%
EPS	$-4.41	$3.88	$2.97	$3.15	$-3.98

Company Overview

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Visit Website

Earnings History & Surprises

CELG-RI

Beat Rate

Last 2 quarters

Avg Surprise

-23.9%

EPS vs Estimate

Beats / Misses

0/2

Last 12 quarters

Latest EPS

$1.08

Q4 2025

EPS Surprise History

Q2 25

-18.8%

$1.21vs$1.49

Q4 25

-28.9%

$1.08vs$1.52

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2025	Oct 30, 2025	$1.52	$1.08	-28.9%	✗ MISS
Q3 2025	Jul 31, 2025	$1.09	—	—	—
Q2 2025	Apr 24, 2025	$1.49	$1.21	-18.8%	✗ MISS
Q3 2023	Sep 30, 2023	—	—	—	—
Q2 2023	Jun 30, 2023	—	—	—	—
Q1 2023	Mar 31, 2023	—	—	—	—
Q4 2022	Dec 31, 2022	—	—	—	—

Frequently Asked Questions about CELG-RI

What is CELG-RI's current stock price?

Bristol-Myers Squibb Company Ce (CELG-RI) is currently trading at $0.04 per share. The stock has moved +19.62% today.

What is the analyst price target for CELG-RI?

No analyst price targets are currently available for this stock.

What sector is Bristol-Myers Squibb Company Ce in?

Bristol-Myers Squibb Company Ce operates in the Healthcare sector, specifically within the Drug Manufacturers - General industry. The company is traded on the NYSE exchange.

What is CELG-RI's market cap?

Bristol-Myers Squibb Company Ce has a market capitalization of $0.09 billion, making it a small-cap company.

Does CELG-RI pay dividends?

No, Bristol-Myers Squibb Company Ce does not currently pay a dividend to shareholders.